<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="monograph" /><meta name="keywords" content="Adalimumab: rheumatic diseases; Humira" /><meta name="IX" content="Humira" /><meta name="IXM" content="Adalimumab: rheumatic diseases" /><title>ADALIMUMAB: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="128230.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="128230.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=128230.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a> &gt; <a href="2077.htm">10 Musculoskeletal and joint diseases</a> &gt; <a href="5182.htm">10.1 Drugs used in rheumatic diseases and gout</a> &gt; <a href="5288.htm">10.1.3 Drugs that suppress the rheumatic disease process</a> &gt; <a href="202659.htm">Cytokine modulators</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="130136.htm" title="Previous: ABATACEPT">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="128231.htm#_128231" title="Next: Humira®">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>AHFS Drug Information</h3></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a302046.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Adalimumab</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Miscellaneous Therapeutic Agents 92:00 &gt; Disease-modifying Antirheumatic Drugs 92:36</p></div></li></ul><ul><li><h3>Stockley's Interaction Alerts</h3></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/19831-m.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Adalimumab</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: A &gt; Interactions of Adalimumab</p></div></li></ul><ul><li><h3>British National Formulary (6)</h3></li><li><a href="100022.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Inflammatory bowel disease</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 1 Gastro-intestinal system &gt; 1.5 Chronic bowel disorders</p></div></li><li><a href="128210.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Cytokine modulators</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 1 Gastro-intestinal system &gt; 1.5 Chronic bowel disorders &gt; 1.5.3 Drugs affecting the immune response</p></div></li><li><a href="200265.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">ADALIMUMAB</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 1 Gastro-intestinal system &gt; 1.5 Chronic bowel disorders &gt; 1.5.3 Drugs affecting the immune response &gt; Cytokine modulators</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22adalimumab%22%22adalimumab%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (6)</a></li></ul><ul><li><h3>BNF for Children (3)</h3></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/128229.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Cytokine modulators</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 10 Musculoskeletal and joint diseases &gt; 10.1 Drugs used in rheumatic diseases &gt; 10.1.3 Drugs that suppress the rheumatic disease process &gt; Drugs affecting the immune response</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/201826.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">ADALIMUMAB</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 10 Musculoskeletal and joint diseases &gt; 10.1 Drugs used in rheumatic diseases &gt; 10.1.3 Drugs that suppress the rheumatic disease process &gt; Drugs affecting the immune response &gt; Cytokine modulators</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/201827.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Humira®</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 10 Musculoskeletal and joint diseases &gt; 10.1 Drugs used in rheumatic diseases &gt; 10.1.3 Drugs that suppress the rheumatic disease process &gt; Drugs affecting the immune response &gt; Cytokine modulators &gt; ADALIMUMAB</p></div></li></ul><ul><li><h3>Injectable Drugs Guide</h3></li><li><a href="http://www.medicinescomplete.com/mc/idg/2010/A06-mn0001.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Adalimumab</a><div class="breadcrumb"><p><strong>Injectable Drugs Guide</strong> &gt; Injectable Drugs Guide &gt; Monographs &gt; A</p></div></li></ul><ul><li><h3>Martindale: The Complete Drug Reference</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/19831-m.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Adalimumab</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Analgesics Anti-inflammatory Drugs and Antipyretics &gt; Drug Monographs</p></div></li></ul><ul><li><h3>The Merck Index</h3></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/00148.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Adalimumab</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; A &gt; AD</p></div></li></ul><ul><li><h3>Stockley's Drug Interactions</h3></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E0E0E14E3E0R0D2263.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Adalimumab</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; A</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1 id="_128230">ADALIMUMAB</h1><?highlighter on?><div id="pC" class="jN"><div class="cAJ"><span class="cAD">Additional information</span> interactions (<a href="41001i988.htm" title="Go to appendix 1">Adalimumab</a>).</div><div class="cAF"><h2>Indications</h2> <p class="cAF">see under <a title="BNF:target-block: Adalimumab-arthritis" href="202659.htm#_208116">Cytokine Modulators</a> above; Crohn’s disease
(<a title="BNF:monograph: ADALIMUMAB" href="200265.htm#_200265">section 1.5.3</a>); psoriasis (<a title="BNF:monograph: ADALIMUMAB" href="201651.htm#_201651">section 13.5.3</a>)</p></div><div class="cAF" id="_200378"><h2>Cautions</h2> <p class="cAF">predisposition to infection; monitor for infection before, during, and for 5 months after treatment (see also Tuberculosis below); do not initiate until
active infections are controlled; discontinue
if new serious infection develops; hepatitis
B virus—monitor for active infection; children should
be brought up to date with current immunisation schedule (<a title="topic: Immunisation schedule" href="38311.htm#_38311">section 14.1</a>) before initiating therapy; mild
heart failure (discontinue if symptoms develop or worsen—avoid in
moderate or severe heart failure); demyelinating CNS disorders (risk of exacerbation); history or development of malignancy; monitor for non-melanoma skin cancer before and during treatment,
especially in patients with a history of PUVA treatment for psoriasis
or extensive immunosuppressant therapy;<b> interactions:</b> Appendix 1 (adalimumab)</p><div class="cAV"><h3>Tuberculosis</h3> <p class="cAX">Patients should be evaluated
for tuberculosis before treatment. Active tuberculosis
should be treated with standard treatment (<a title="sub-section: Antituberculous drugs" href="3899.htm#_3899">section 5.1.9</a>) for at least 2 months before
starting adalimumab. Patients who have previously received
adequate treatment for tuberculosis can start adalimumab but should
be monitored every 3 months for possible recurrence. In patients without active tuberculosis but who were previously not
treated adequately, chemoprophylaxis should ideally be completed before
starting adalimumab. In patients at high
risk of tuberculosis who cannot be assessed by tuberculin skin test,
chemoprophylaxis can be given concurrently with adalimumab. Patients should be advised to seek medical attention
if symptoms suggestive of tuberculosis (e.g. persistent cough, weight
loss, and fever) develop</p></div><div class="cAV"><h3>Blood disorders</h3> <p class="cAX">Patients should be
advised to seek medical attention if symptoms suggestive of blood
disorders (such as fever, sore throat, bruising, or bleeding) develop</p></div></div><div class="cAF" id="_200380"><h2>Contra-indications</h2> <p class="cAF">severe infection (see also Cautions)</p></div><div class="cAF"><h2>Pregnancy</h2> <p class="cAF">avoid; manufacturer advises effective contraception
required during treatment and for at least 5 months after last dose</p></div><div class="cAF"><h2>Breast-feeding</h2> <p class="cAF">avoid; manufacturer advises avoid for at least
5 months after last dose</p></div><div class="cAF" id="_201654"><h2>Side-effects</h2> <p class="cAF">see under <a title="BNF:target-block: Cytokine inhibitor side-effects notes 10.1.3" href="202659.htm#_200785">Cytokine Modulators</a> and Cautions above; also vomiting, dyspepsia, gastro-intestinal
haemorrhage; dizziness, hyperlipidaemia, hypertension, oedema, flushing,
chest pain, tachycardia; cough, dyspnoea; mood changes, sleep disturbances,
anxiety, paraesthesia; haematuria, renal impairment; benign tumours,
skin cancer; electrolyte disturbances, hyperuricaemia; musculoskeletal
pain; eye disorders; rash, dermatitis, onycholysis, impaired healing; <i>less commonly</i> dysphagia, pancreatitis, cholelithiasis, hepatic
steatosis, cholecystitis, arrhythmias, interstitial lung disease,
pneumonitis, tremor, erectile dysfunction, nocturia, malignancy (including
solid tumours, lymphoma, and leukaemia), rhabdomyolysis, hearing loss,
tinnitus; <i>rarely</i> vascular occlusion, myocardial infarction,
demyelinating disorders; <i>also reported</i> pulmonary
embolism, pleural effusion, sarcoidosis, Stevens-Johnson syndrome,
cutaneous vasculitis, new onset or worsening psoriasis</p></div><div class="cAF"><h2>Dose</h2> <p class="cR"><span class="cU">By subcutaneous injection</span>, rheumatoid
arthritis, <span class="cAK">adult</span> over 18 years, 40 mg
on alternate weeks; if necessary increased to 40 mg weekly in patients
receiving adalimumab alone; review treatment if no response within
12 weeks</p><p class="cS">Polyarticular juvenile idiopathic arthritis, <span class="cAK">child</span> 4–12 years, 24 mg/m<sup>2</sup> (max. 40 mg)
on alternate weeks; <span class="cAK">child</span> 13–17 years,
40 mg on alternate weeks; review treatment if no response within 12
weeks</p><p class="cS">Psoriatic arthritis, ankylosing spondylitis, <span class="cAK">adult</span> over 18 years, 40 mg on alternate weeks; discontinue
treatment if no response within 12 weeks</p></div></div><?highlighter on?><div id="pS"><p>Sub-sections</p><ul class="jT"><li><a href="128231.htm#_128231" title="Humira®">Humira®</a></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="130136.htm">Previous: ABATACEPT</a> | <a class="top" href="128230.htm#">Top</a> | <a accesskey="]" href="128231.htm#_128231" title="Humira®">Next: Humira®</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>